Writing the Next Chapter in Precision Medicines for Patients With Cancer

Discovering and developing the next generation of oncology precision medicines through:

Industry leaders with a proven track record of success

Building a broad pipeline of potentially best-in-class tumor-agnostic therapies

News

March 10, 2025
OnKure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
March 4, 2025
OnKure Therapeutics to Present at Upcoming Leerink and Stifel Investor Conferences
December 10, 2024
OnKure Announces Encouraging Preliminary Safety, Tolerability, and Pharmacokinetic (PK) Data from its First-In-Human PIKture-01 Trial of OKI-219
View All News